CosmosID unveils new tool for faster, specific and accurate testing of probiotics products
The FDA and CosmosID conducted side-by-side analysis of commercially available probiotics to compare species and strains with labeling claims. CosmosID's GENIUS product outperformed the FDA's k-mer approach in terms of speed and specificity.